Carborane clusters increase the potency of bis-substituted cyclam derivatives against Mycobacterium tuberculosis.
RSC Med Chem
; 13(10): 1234-1238, 2022 Oct 19.
Article
en En
| MEDLINE
| ID: mdl-36325397
Bis-substituted cyclam derivatives have recently emerged as a promising new class of antibacterial agents, displaying excellent activity against drug-resistant Mycobacterium tuberculosis (Mtb) and in vivo efficacy in a zebrafish assay. Herein we report the synthesis and biological activity of new carborane derivatives within this class of antitubercular compounds. The resulting carborane-cyclam conjugates incorporating either hydrophobic closo-1,2-carborane or anionic, hydrophilic nido-7,8-carborane clusters display promising activity in an antibacterial assay employing the virulent Mtb strain H37Rv. The most active of these carborane derivatives exhibit MIC50 values of <1 µM, making them the most active compounds in this unique class of antibacterial cyclams reported to date.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Idioma:
En
Revista:
RSC Med Chem
Año:
2022
Tipo del documento:
Article
Pais de publicación:
Reino Unido